ASHLEY HOFFMAN: Open Payments
NPI 1629667407 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 42 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $374 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $426 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| GENZYME CORPORATION | 5 | $102 |
| Grifols USA, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
Products named: NUCALA, BREZTRI, DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, Prolastin-C Liquid, ARALAST, Ohtuvayre.
Industry payments across NJ — which companies pay providers there.
